|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.920 HKD | +0.73% |
|
+0.44% | +7.29% |
| 01-07 | Sichuan Kelun-Biotech Subscribes to Wealth Management Products | MT |
| 01-06 | Sichuan Kelun-Biotech Biopharmaceutical subscribes for wealth management products | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 15.35B | 13.3B | 13.84B | 203B | 78.12B | |||||
Investment Securities, Total | 3,336B | 3,497B | 3,898B | 4,217B | 4,282B | |||||
Trading Asset Securities, Total | 537B | 678B | 775B | 710B | 757B | |||||
Total investments | 3,873B | 4,174B | 4,673B | 4,926B | 5,038B | |||||
Gross Loans | 5,848B | 6,560B | 7,315B | 7,978B | 8,788B | |||||
Allowance For Loan Losses | -139B | -160B | -176B | -204B | -225B | |||||
Other Adjustments to Gross Loans | - | - | - | - | - | |||||
Net Loans | 5,709B | 6,400B | 7,139B | 7,775B | 8,563B | |||||
Gross Property Plant And Equipment | 252B | 260B | 295B | 328B | 359B | |||||
Accumulated Depreciation | -75.89B | -82.48B | -93.85B | -103B | -114B | |||||
Net Property Plant And Equipment | 176B | 178B | 201B | 224B | 246B | |||||
Goodwill | 401M | 395M | 407M | 415M | 399M | |||||
Other Intangibles, Total | 3.61B | 3.87B | 3.95B | 4.63B | 4.84B | |||||
Investment in Real Estate | 7.35B | 6.34B | 6.39B | 5.52B | 5.46B | |||||
Accrued Interest Receivable | 18.61B | 20.31B | 5.25B | 5.87B | 26.89B | |||||
Other Receivables | 201B | 182B | 189B | 144B | 221B | |||||
Restricted Cash | 634B | 624B | 683B | 694B | 638B | |||||
Other Current Assets, Total | 22.96B | 21.66B | 30.41B | 26.3B | 27.42B | |||||
Deferred Tax Assets Long-Term (Collected) | 27.99B | 32.06B | 38.77B | 40.38B | 42.75B | |||||
Other Real Estate Owned And Foreclosed | 967M | 1.03B | 1B | 945M | 523M | |||||
Deferred Charges Long-Term | 599M | 721M | 879M | 1.19B | 1.06B | |||||
Other Long-Term Assets, Total | 6.14B | 6.77B | 6.84B | 8.6B | 7.34B | |||||
Total Assets | 10,698B | 11,666B | 12,992B | 14,060B | 14,901B | |||||
Liabilities | ||||||||||
Accrued Expenses, Total | 15.8B | 20.04B | 21.74B | 23.49B | 26.2B | |||||
Interest Bearing Deposits | 4,363B | 4,937B | 6,077B | 6,537B | 7,144B | |||||
Non-Interest Bearing Deposits | 2,818B | 2,913B | 2,874B | 2,935B | 2,911B | |||||
Total Deposits | 7,181B | 7,850B | 8,952B | 9,472B | 10,055B | |||||
Short-Term Borrowings | 720B | 1,117B | 1,029B | 1,289B | 1,494B | |||||
Current Portion of Long-Term Debt | 1,111B | 863B | 1,043B | 1,162B | 1,074B | |||||
Current Portion of Leases | 8.44B | - | - | - | - | |||||
Long-Term Debt | 483B | 485B | 524B | 599B | 642B | |||||
Long-Term Leases | 24.92B | 31.74B | 18.39B | 19.12B | 6.54B | |||||
Current Income Taxes Payable | 3.79B | 4.72B | 3.94B | 4.54B | 8.06B | |||||
Accrued Interest Payable | 68.08B | 83.59B | 119B | 156B | 167B | |||||
Other Current Liabilities - (Bank / Utility Template) | 54.82B | 40.29B | 59B | 59.88B | 71.6B | |||||
Pension & Other Post Retirement Benefits | - | - | - | - | - | |||||
Deferred Tax Liability Non-Current | 1.29B | 1.89B | 1.79B | 2.41B | 4.32B | |||||
Other Non Current Liabilities | 146B | 193B | 185B | 174B | 196B | |||||
Total Liabilities | 9,819B | 10,689B | 11,957B | 12,961B | 13,745B | |||||
Preferred Stock Convertible | 44.95B | 44.95B | 44.95B | 44.95B | 44.95B | |||||
Total Preferred Equity | 44.95B | 44.95B | 44.95B | 44.95B | 44.95B | |||||
Common Stock, Total | 74.26B | 74.26B | 74.26B | 74.26B | 74.26B | |||||
Additional Paid In Capital | 111B | 111B | 111B | 111B | 111B | |||||
Retained Earnings | 550B | 608B | 667B | 723B | 768B | |||||
Comprehensive Income and Other | 85.99B | 126B | 127B | 134B | 146B | |||||
Total Common Equity | 822B | 920B | 978B | 1,043B | 1,099B | |||||
Minority Interest | 12.02B | 12.59B | 12.33B | 11.42B | 11.29B | |||||
Total Equity | 879B | 977B | 1,036B | 1,099B | 1,156B | |||||
Total Liabilities And Equity | 10,698B | 11,666B | 12,992B | 14,060B | 14,901B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 74.26B | 74.26B | 74.26B | 74.26B | 74.26B | |||||
ECS Total Common Shares Outstanding | - | 74.26B | 74.26B | 74.26B | 74.26B | |||||
Book Value / Share | 9.87 | 10.64 | 11.43 | 12.3 | 13.06 | |||||
Tangible Book Value | 818B | 915B | 974B | 1,038B | 1,094B | |||||
Tangible Book Value Per Share | 9.82 | 10.58 | 11.37 | 12.23 | 12.98 | |||||
Average Assets | 10,742B | 11,407B | 12,613B | 13,872B | 14,391B | |||||
Average Loans | 5,522B | 6,154B | 6,935B | 7,742B | 8,265B | |||||
Total Debt | 2,348B | 2,495B | 2,614B | 3,069B | 3,216B | |||||
Deposits at Interest - Cash | 135B | 90.66B | 235B | 263B | 148B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 467M | 385M | 396M | 331M | 320M | |||||
Net Debt | 1,219B | 1,198B | 1,186B | 1,411B | 1,776B | |||||
Equity Method Investments, Total | 4.68B | 5.78B | 8.75B | 8.99B | 11.6B | |||||
Full Time Employees | - | 90.24K | 91.82K | 94.28K | 95.75K | |||||
Number Of Offices | - | 2.8K | 2.79K | 2.8K | 2.8K | |||||
Assets on Operating Lease - Gross | - | - | - | 202B | 232B | |||||
Assets on Operating Lease - Accumulated Depreciation | - | - | - | -39.5B | -45.28B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















